{"id":229761,"date":"2025-03-28T00:00:00","date_gmt":"2025-03-28T00:00:00","guid":{"rendered":"http:\/\/clarivate.com\/life-sciences-healthcare\/report\/47041150-medtech-peripheral-vascular-devices-market-insights\/"},"modified":"2026-04-14T10:02:50","modified_gmt":"2026-04-14T10:02:50","slug":"47042551-medtech-peripheral-vascular-devices-market-insights-latin-america","status":"publish","type":"report","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/47042551-medtech-peripheral-vascular-devices-market-insights-latin-america\/","title":{"rendered":"Peripheral Vascular Devices &#8211; Market Insights &#8211; Latin America"},"content":{"rendered":"<p>The Latin American\u00a0<abbr title=\"Peripheral Vascular\">PV<\/abbr> device market will see increasing penetration of endovascular techniques and increasing uptake of premium-priced products, such as drug-eluting technologies and <abbr title=\"Intravascular Lithotripsy\">IVL<\/abbr>, as well as a particular focus on procedures treating iliac and lower-limb arteries. Nevertheless, price competition, unfavorable reimbursement, and unwillingness by some\u00a0clinicians to adopt new technologies will limit revenue growth to some extent.<\/p>\n<p>This Medtech 360 Report provides comprehensive data and analysis on the state of the market for <abbr title=\"Peripheral Vascular\">PV<\/abbr> devices in Latin America from 2019 through 2033.<\/p>\n<p><strong>Uptake of premium-priced technologies will drive growth in the market.<\/strong><\/p>\n<p>To what degree will <abbr title=\"Drug-Eluting Stent(s)\">DES<\/abbr> and <abbr title=\"Drug-Coated Balloon\">DCB<\/abbr>s be adopted in Latin America over the forecast period? How will the adoption affect use of other <abbr title=\"Peripheral Vascular\">PV<\/abbr> stents or <abbr title=\"Percutaneous Transluminal Angioplasty\">PTA<\/abbr> balloons, respectively?<\/p>\n<p>How is the adoption of <abbr title=\"Intravascular Lithotripsy\">IVL<\/abbr> for <abbr title=\"Peripheral Vascular\">PV<\/abbr> indications going to impact the <abbr title=\"Peripheral Vascular\">PV<\/abbr> device market?<\/p>\n<p><strong>Recently published positions and guidelines from key organizations are expected to impact the adoption of paclitaxel-eluting devices.<\/strong><\/p>\n<p>How will the recent <abbr title=\"Food and Drug Administration\">FDA<\/abbr> letter concerning paclitaxel-based devices affect device choice in Latin America?<\/p>\n<p>What is the current position about paclitaxel-eluting device among physicians? How will these updates affect to other alternative drug-eluting devices in the market?<\/p>\n<div>\n<p class=\"question-statement\"><strong>Competitors are developing <abbr title=\"Drug-Eluting Stent(s)\">DES<\/abbr> and <abbr title=\"Drug-Coated Balloon\">DCB<\/abbr>s that do not use paclitaxel.<\/strong><\/p>\n<p>What companies are developing these products?<\/p>\n<p>What impact will the approval of such products have on use of existing devices?<\/p>\n<p><strong>Procedure volume growth will be supported by increasing interventional endovascular techniques in iliac, <abbr abbreviation-entity-id=\"9159\" data-display-abbreviation=\"Fem-Pop\" title=\"Femoropopliteal\">fem-pop<\/abbr>, and <abbr abbreviation-entity-id=\"9160\" data-display-abbreviation=\"Infrapop\" title=\"Infrapopliteal\">infrapop<\/abbr> indications.<\/strong><\/p>\n<p>Which devices are expected to see the greatest uptake in these indications??<\/p>\n<p>How has this focus impacted the <abbr title=\"Peripheral Vascular\">PV<\/abbr> device market?<\/p>\n<p><b>M&#038;A activities or partnerships involving key competitors may lead to shifts in market shares going forward.<\/b><\/p>\n<p>Which acquisitions have occurred, and how will these acquisitions impact competitor performance in the future?<\/p>\n<p>How are competitors leveraging product portfolio acquisitions to expand their product offerings?<\/p>\n<\/div>\n<p class=\"question-statement\"><b>Endovascular treatment of <abbr title=\"Peripheral Vascular Disease\">PVD<\/abbr>s is increasing in Latin America.<\/b><\/p>\n<p>Which country has the highest penetration of endovascular procedures?<\/p>\n<p>What factors influence the selection of\u00a0different approaches to perform\u00a0endovascular procedures among the Latin American countries covered?<\/p>\n<p>Which country will see the highest procedural and market revenue growth?<\/p>\n<p class=\"question-statement\"><strong>Most segments in the Latin American <abbr title=\"Peripheral Vascular\">PV<\/abbr> device market continue to be dominated by large international manufacturers.<\/strong><\/p>\n<p>Which companies are the leading competitors in each of the <abbr title=\"Peripheral Vascular\">PV<\/abbr> device segments?<\/p>\n<p>What competitive strategies will help competitors improve their market\u00a0positions going forward?<\/p>\n","protected":false},"template":"","class_list":["post-229761","report","type-report","status-publish","hentry","report-gateway-medtech","medtech-therapy-area-cardiovascular","medtech-therapy-area-peripheral-vascular-devices","medtech-geography-latin-america","medtech-date-2294"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/229761","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":10,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/229761\/revisions"}],"predecessor-version":[{"id":575103,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/229761\/revisions\/575103"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=229761"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}